Piqray™

Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.

Listen to the audio transcription of the CMI leaflet.

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

PIQRAY in combination with fulvestrant, is indicated for the treatment of postmenopausal women, and men, with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer with a PIK3CA mutation as detected by a validated test following progression on or after an endocrine-based regimen

Source: ARTG

• Shelf lifetime is 48 Months
• Store below 30 degrees Celsius
• Protect from Moisture

Source: ARTG

Composite pack

This medicine is a pack that contains more than one component.

Important: The components listed below are not necessarily in order of use. Please refer to the Consumer Medicine Information (CMI) or consult your doctor for proper administration instructions and sequence.

Component

• Tablet, film coated
• Oral
• Light red, unscored, ovaloid and curved with bevelled edges film-coated tablet, imprinted with YL7 on one side and NVR on the other side

Component

• Tablet, film coated
• Oral
• Light pink, unscored, round and curved with bevelled edges film-coated tablet, imprinted with L7 on one side and NVR on the other side

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• Fourteen (14) 50 mg alpelisib film coated tablets plus fourteen (14) 200 mg alpelisib film coated tablets (250 mg daily dose /14 day pack)
• Twenty eight (28) 50 mg alpelisib film coated tablets plus twenty eight 200 mg alpelisib film coated tablets (250 mg daily dose /28 day pack )

Source: ARTG

This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.

Source: PBS

For the active ingredient: Alpelisib

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Source: AHT

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).